Fennec Pharmaceuticals Inc
NAS:FENCHealthcareCBOEFTSE:MRUTnasdaq_composite$10.05−2.62%LiveIn session · ≈ AED 36.91 · Market cap $352.42M · Next earnings Thu 5 Nov
EPS: actual vs estimate
Beat (%) vs consensus · next report Thu 5 Nov
Next report
DateThu, 5 Nov 2026
EPS estimate0.13
Revenue estimate19.1m
Currency—
Last reports
| Report | EPS estimate | EPS actual | EPS surprise | Revenue estimate (m) | Revenue actual (m) | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-08-11 | 0.02 | 0.05 | +171.0% | 16.2 | 17.9 | +10.3% |
| 2026-05-14 | −0.02 | 0.01 | +150.0% | 13.9 | 15.1 | +8.6% |
| 2026-03-24 | 0.03 | −0.11 | −466.7% | 14.7 | 13.8 | −6.5% |
| 2025-11-13 | −0.08 | −0.02 | +75.0% | 14.7 | 12.5 | −15.2% |
| 2025-08-14 | −0.06 | −0.11 | −83.3% | 9.6 | 9.7 | +0.9% |
| 2025-05-13 | −0.12 | −0.04 | +66.7% | 9.0 | 8.8 | −3.2% |
| 2025-03-10 | 0.56 | −0.06 | −110.7% | 7.8 | 7.9 | +1.6% |
| 2024-11-07 | −0.13 | −0.21 | −61.5% | 8.0 | 7.0 | −12.9% |
| 2024-08-13 | 0.06 | −0.20 | −433.3% | 11.1 | 7.3 | −34.3% |
| 2024-05-14 | 0.26 | 0.47 | +80.8% | 18.9 | 25.4 | +34.4% |
| 2024-03-21 | −0.02 | −0.10 | −400.0% | 8.7 | 9.7 | +12.3% |
| 2023-11-06 | −0.11 | −0.07 | +36.4% | 8.1 | 6.5 | −19.2% |
Currency not supplied by the earnings feedUpdated Tue 11 Aug ·
ⓘ
Surprise is actual minus consensus, as a share of the consensus.
